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Abstract
Background: Discussion has continued for Calorie
Restriction (CR) and low carbohydrate diet (LCD). We have
investigated clinical research of LCD in various states for
years.
Case and results: The patient was 61 year-old female with
HbA1c 10.5%, BMI 21.2 kg/m2 and normal vitals and
physicals. Laboratory data were Hb 15.2 g/dl, Alb 5.0 g/dL,
Triglyceride 43 mg/dL, HDL-C 89 mg/dL, LDL-C 152 mg/dL,
immunoreactivity insulin (IRI) 2.9 μU/mL serum C-peptide
reactivity (s-CPR) 1.0 ng/mL, total ketone bodies (T-KB)
3081 μmol/L (28-120), acetoacetic acid (AcAc) 300 μmol/L
(14-68), 3-hydroxybutyric acid (3-OHBA) 2781 μmol/L
Autoantibodies  were negative for Glutamate
decarboxylase (GADA) or Islet cell (IA-2). She was
diagnosed as type 2 diabetes mellitus (T2DM) and started
super LCD formula meal with 12% of carbohydrate, and
recorded carbohydrate amount about 20-40g per day.
HbA1c value was 8.1% and 6.6% in 2 and 4 months,
respectively. Significant relationship was shown between
carbohydrate intake and hyperketonemia. AcAc/T-KB ratio
was 15-20% and around 10%, when T-KB is less than 1000
μmol/L and more than 1000 μmol/L, respectively.
Discussion and conclusion: Authors have proposed 3
types of LCD, which are petit, standard and super, with
40%, 26%, 12% of carbohydrate ratio. Continuing super-
LCD usually brings elevated ketone bodies, which might
have beneficial function for maintaining the health and
anti-aging medicine. Currently obtained results would
become the fundamental data and suppose future
directions and recommendations for research of ketone
bodies in low carbohydrate diet.
Keywords: Low carbohydrate diet; Super low
carbohydrate diet; 3-Hydroxybutyric acid; Acetoacetic
acid; Ketone bodies; Hyperketonemia
Abbreviations: LCD: Low-Carbohydrate Diet; CR: Calorie
Restriction; T2DM: Type 2 Diabetes Mellitus; VLCKD: Very
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Hydroxybutyric Acid; IRI: Insulin Immunoreactivity; CPR:
C-Peptide Reactivity
Introduction
Concerning the nutritional therapy, lots of discussion have
been continued in comparison with Calorie Restriction (CR)
and low carbohydrate diet (LCD). LCD has been originated by
Atkins and Bernstein in western countries [1,2]. After that, LCD
has been reported to have various clinical efficacy by several
investigators [3-6]. Clinical efficacy of LCD for 2 years
compared with CR and Mediterranean diet and similar efficacy
for 4 years were shown [3,4]. Consecutively, several
researchers reported clinical research of LCD in the light of
various axes [5-7].
On contrast, in Japan, the authors firstly initiated LCD and
reported the effect of LCD in clinical practice [8,9]. We
proposed useful three kinds of LCD formula diet, which are
super LCD, standard LCD and petit LCD, which have been
clinically effective for patients with diabetes and metabolic
disease and patients necessary to reduce weight [10,11]. With
these clinical nutritional therapy, we have also developed
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social movement, continuing the activity of Japan LCD
Promotion Association with lectures and journals.
Furthermore, we have investigated LCD in patients with
various states including fetus-placenta-newborn-mother axis.
We have reported the results that remarkable elevated ketone
bodies are found in these axes, and that these findings would
suggest the important roles of ketone bodies as an energy
source [12,13].
The characteristic effect of LCD would be elevated level of
ketone bodies in blood [14,15]. From the biochemical point of
view, ketone bodies include three elements, which are 1)
acetoacetic acid (AcAc), 2) β-hydroxybutyric acid (3-OHBA),
and 3) acetone. Concentration increases and decreases
alternately between AcAc and 3-OHBA, which has biological
effect as ketone bodies [16,17].
On the other hand, from the clinical point of view,
hyperketonemia has been usually classified into diabetic
ketoacidosis (DKA) and physiological ketosis. The former is
observed in extremely elevated blood sugar with acidosis. The
latter is observed in normal blood sugar or during a prolong
fast without clinically risky acidosis [18], and is from persisting
starvation or ketogenic diet (KD). A ketogenic diet (KD) has
traditionally comprised high fat, moderate/ low protein, and
very low carbohydrate intake and aimed to induce a state of
nutritional ketosis [19].
In the category of LCD by Feinman and Bernstein, it is called
Very Low-Carbohydrate Ketogenic Diet (VLCKD). The
characteristic points of VLCKD are in the following. It contains
of carbohydrate about 20–50 g/d or <10% of the 2000 kcal/d
diet, whether or not ketosis occurs, and derived from levels of
carbohydrate required to induce ketosis in most people, with
recommendation for early phase of popular diets such as
Atkins Diet or Protein Power [7]. Consequently,
hyperketonemia has been recognized to be clinically stable and
safe condition as the secondary effect of VLCKD.
We have treated many patients with diabetes and metabolic
syndrome by clinically application of LCD for years. In this
study, we investigated the patient with type 2 diabetes
mellitus (T2DM), who started super LCD meal describing the
detail analysis of carbohydrate intake for long time, associated
with remarkable elevated serum ketone bodies.
Case Presentation
The patient was 61 year-old female, who has been teaching
yoga for years. When she was 51 years old, she was pointed
out as T2DM. During treatment of oral agents, her liver
function tests developed abnormality. Then, she discontinued
the therapy, and she herself continued just meal and exercise
therapy for 10 years.
She occasionally attended our medical seminar for LCD, then
she came to check diabetic status. The HbA1c level was 10.5%,
and she visited our diabetic clinic 2 weeks later. Consequently,
we started further evaluation and treatment for diabetes.
In first contact, she showed no particular symptoms such as
thirsty, polydipsia, polyuria, fatigue or weight loss which are
characteristic for diabetes. On physical examination, she
showed 158 cm in height, 53 kg in weight, BMI 21.2 kg/m2.
Her vitals and consciousness are normal, and lung, heart,
abdomen and neurological findings were unremarkable.
Laboratory tests
General laboratory data were as follows: Hb 15.2 g/dl, WBC
4400/μL, Alb 5.0 g/dL, Triglyceride 43 mg/dL, HDL-C 89 mg/dL,
LDL-C 152 mg/dL. There were no abnormal results in serum
amylase, TSH, free T4, liver function tests.
Specific laboratory data concerning diabetes were as
follows: HbA1c 9.4%, blood glucose 178 mg/dL,
Immunoreactivity insulin (IRI) 2.9 μU/mL (3-15), HOMA-R 1.28,
HOMA-β 9.01, serum C-peptide reactivity (s-CPR) 1.0 ng/mL
(1.1-4.4), urinary C-peptide reactivity (u-CPR) 15 mg/day
(28-120), Total ketone bodies 3081 μmol/L (28-120),
acetoacetic acid (AcAc) 300 μmol/L (14-68), 3-hydroxybutyric
acid (3-OHBA) 2781 μmol/L (0-74), Autoantibodies to
Glutamate decarboxylase (GADA) <1.4 U/ml (<1.4), Islet cell
autoantibodies (IA-2) <0.4 U/ml (<0.4). Glucagon test revealed
that s-CPR increased from 1.0 to 1.8 ng/mL in response to
glucagon injection. Chest X-P and abdominal CT scan revealed
unremarkable findings.
Diet therapy for super LCD
As to the diet therapy for diabetes, the options were
proposed for the patient to choose whether traditional calorie
restriction (CR) diet or low carbohydrate diet (LCD). She chose
LCD with her perfect understanding for the medical knowledge
as a yoga teacher.
Furthermore, we proposed 3 kinds of LCD, which are super
LCD with 12% of carbohydrate, standard LCD with 26% of
carbohydrate and petit LCD with 40% of carbohydrate. We
consulted the detail of actual LCD continuation, and decided to
choose super LCD.
The detail of the LCD was calculated as follows: ideal weight
(kg) is 1.58 × 1.58 × 22=54.9 kg, daily calorie taken per day is
54.9 kg × 25 kcal/kg/day=1373 kcal/day, which is
approximately 1400 kcal/day.
We adopted super-LCD formula meal with 12% of
carbohydrate which was originated by Dr. Ebe, one of the
authors [8-11]. Consequently, the calculation was that 1400
kcal × 0.12=168 kcal by carbohydrate per day, and 168 kcal/4
kcal=42 g of carbohydrate in a day.
Patient could make the menu of LCD and also cook with less
carbohydrate. Some samples from the actual meals are shown
in Figure 1, in which perfect calculation of each food including
carbohydrate was found. Generally speaking, Japanese style
meal usually contains rice, cereal or noodles. However, the
actual meal (Figure 1) has almost none carbohydrate or staple
food usually included in Asian countries.
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Figure 1 Actual meal of low carbohydrate diet and its
carbohydrate amount.
Efficacy of LCD for diabetes
As the patient has started and continued LCD, HbA1c value
has decreased from 10.5%, to 9.3% 8.1%, 7.2% and 6.6% in 4
months (Figure 2). After that, HbA1c maintained stable in
normal range from 4 to 12 months (Figure 2).
Figure 2 Improvement of HbA1c in the treatment of low
carbohydrate diet.
Blood glucose levels were around 170 mg/dL in 0-3 months,
150 mg/dL in 4-7 months and 130 mg/dL in 8-12 months. The
values of IRI were stable from 2.9 μU/mL to 4.8 μU/mL during
12 months. The values of serum CPR were stable from 0.9
ng/mL to 1.3 ng/mL during 12 months.
Correlations of biomarkers
The patient has continued LCD, and showed the elevated
blood ketone bodies. She also continued taking food
photograph and carbohydrate analyses every day.
Consequently, the precise relationship between carbohydrate
intake amount and the serum level of ketone bodies during 12
months could be investigated, which indicated the significant
correlation between the both factors (p<0.05) (Figure 3).
When the carbohydrate amount is about less than 30 g/day,
total ketone bodies (T-KB) was increased to moderate to high
extent. When the carbohydrate amount is 40-60 g/day, T-KB
was increased to moderate extent.
Figure 3 Correlation between carbohydrate intake and total
ketone bodies.
In clinical laboratory examination, total ketone bodies (T-KB)
includes 2 fractions, which are acetoacetic acid (AcAc) and 3-
hydroxybutyric acid (3-OHBA). The ratio of AcAc/T-KB was
investigated, which showed the significant correlation with T-
KB level (p<0.05) (Figure 4). When the T-KB is less than 1000
μmol/L, AcAc ratio revealed approximately 15 -20%. When the
T-KB is more than 1000 μmol/L, AcAc ratio revealed around
10% (Figure 4).
Figure 4 The ratio of acetoacetic acid (AcAc) to total ketone
bodies.
Endocrinology and Metabolism: Open Access
Vol.2 No.1:109
2018
© Copyright iMedPub 3
For statistical analyses in this study, correlation coefficients
were calculated using Spearman or Pearson test of the
Microsoft Excel analytical tool, in reference to the Four steps
Excel Statistics 4th edition [20]. A significance level of less than
5% was judged to be statistically significant.
Discussion
The features of this research are summarized as follows: 1)
diabetic patient was treated by LCD leading to improved
HbA1c, 2) actual carbohydrate amount per day was
investigated, 3) significant correlation was shown between
carbohydrate amount and serum ketone bodies and 4) ratio of
fraction of ketone bodies was examined.
As nutritional therapy, there have been CR and LCD so far.
Standard CR diet in Japan was decided according to the
guideline of Japan Diabetes Society, in which PFC ratio is
14.7%, 26.9%, 58.4%, respectively [21]. This ratio has not been
changed from 1985 to 2015 on the national survey [22]. In
general, PFC ratio has been approximately 15:25:60.
On the other hand, authors proposed three patterns of LCD,
which are super LCD, standard LCD and petit LCD. The
carbohydrate ratio of them are, 12%, 26% and 40%,
respectively. Thus, super LCD has nutritional balance with
carbohydrate 12%, protein 32% and fat 56% [8-11].
In United States, American Diabetes Association (ADA)
recommended that carbohydrate intake per day would be less
than 130 g or less than 26% total energy per day [23,24]. This
ratio of 26% is consistent with the standard LCD among the
three types of LCD that we have proposed so far.
The definition of LCD has been waited worldwide, because
there are lots of nutritional pattern and food habits. Along
with the definition of Bernstein et al., nutrition diet has been
classified into several categories [7]. They are 1) Very low-
carbohydrate ketogenic diet (VLCKD): Carbohydrate, 20–50 g/d
or <10% of the 2000 kcal/d diet, 2) Low-carbohydrate diet:
<130 g/d or <26% total energy, 3) Moderate-Carbohydrate
Diet: 26%–45%, 4) High-Carbohydrate Diet: >45%) [7].
Super-LCD is one of VLCKD, and contains 12% of
carbohydrate. Continuing VLCKD makes the patient elevated
ketone bodies and weight reduction due to ketogenesis
[25-28]. With this effect of LCD, authors have treated patients
and developed LCD for years [10,11,13,29].
In this study, super LCD formula meal was continued,
associated with elevated ketone bodies in blood. The
theoretical standard of carbohydrate intake was 42 g per day,
according to the calculation of body size. In fact, the patient
herself devised a meal and checked the detail amount of
carbohydrate every day. Actually, the patient had carbohydrate
7 to 24 g per serving, about 20 to 40 g/day per day, when
carbohydrate restriction began.
Such actual detail report would be rather rare and highly
evaluated in clinical practice. These limitations gradually
relaxed according to the clinical course, associated with
decreasing of HbA1c. There was a significant correlation
between carbohydrate intake amount and ketone body
concentration, which would be remarkable meaningful data.
Concerning the treatment with LCD, ketogenic diet has been
involved in the important role. Under normal physiological
conditions, cells acquire energy from glucose in the process of
glycolysis. As carbohydrate intake is remarkably limited,
glycogen stores in the liver and skeletal muscles would be
decreased [30,31]. Our body responds by shifting part of the
energy source to adipose tissue and utilizing ketone bodies as
by-products. Therefore, ketosis is a metabolic state that
generates energy from these ketone bodies. The rate that
body can supply fuel to the brain and the body is usually 0.5 to
3.0 mg/dL.
Recent   studies  found   that   ketogenic   diet would indicate
beneficial effect during aerobic performance and significant
improvements in maximal oxygen uptake (V̇O2max) and
lactate threshold [32]. There are a significant reduction in the
time for 2,000 m sprint cycle and in aerobic fatigue [33].
Furthermore, ketogenic diet showed 2-fold increase in peak fat
oxidation and 59% increase in mean fat oxidation during
submaximal exercise [34]. Furthermore, increased fat
oxidation would induce lower respiratory exchange ratio (RER),
and improve physical fitness variables such as V̇O2max, lactate
threshold, and maximum heart rate [35].
When lipids burn in the body, blood ketone bodies are
produced. From the biochemical point of view, ketone bodies
include three elements, which are AcAc, 3-OHBA and acetone.
Concentration increases and decreases alternately between
AcAc and 3-OHBA, and acetone has no biological effect. The
degree of fat burning is estimated by measuring AcAc and 3-
OHBA. If it is high, it has the evidence that fat is burning at
present. In clinical practice, AcAc and 3-OHBA are summed up
and measured as total ketone bodies.
In this study, the ratio of AcAc and 3-OHBA in total ketone
bodies were investigated. There is two pathophysiological case
in hyperketonemia, which are diabetic ketoacidosis (DKA) and
physiological ketosis. DKA revealed that blood glucose level is
more than 300 mg/dL associated with acidosis, and ketone
bodies level would be about 20-25 mmol/L (20,000-25,000
μmol/L) [18,36]. Previous report concerning DKA revealed that
the average data were glucose 650 mg/dL, pH 7.13, T-KB 10.2 ±
1.8 mmol/L, AcAc 2.7 ± 0.5 mmol/L, 3-OHBA 7.5 ± 1.3 mmol/L
and the ratio of 3-OHBA 74% [37].
On contrast, in physiological ketosis, blood glucose is normal
and plasma ketone bodies would increase to 6-8 mmol/L
(6000-8000 μmol/L) during a prolonged fast [18]. The cause
would be from prolonged starvation and ketogenic diet, which
was proposed by biochemist Crebs given Nobel Prize [38].
In recent years, clinical significance of hyperketonemia has
been in focus, because of the possibilities for various beneficial
function [39-41]. Regarding the fragments of ketone bodies, 3-
OHBA has been said to express the various efficacy and has
acted as a ligend to the G-protein coupled GPR 109, resulting
in anti-inflammatory properties [15,41,42]. Consequently,
current results concerning the ratio of AcAc and 3-OHBA
would be the fundamental data for future research.
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The beneficial function of ketone bodies will be more in
focus in anti-aging medicine. Several clinical positive effects
are as follows: Ketone bodies can burn fatty acids well,
becomes healthy and excellent diet, suppresses aging caused
by hyperglycemia, develops to comprehensive anti-aging, and
prevents dementia. In this way, by limiting carbohydrate
intake, the switch in the ketone body circuit becomes turning
on.
As a result, the longevity gene Sirt 3 is activated, and the
metabolism of the ketone body is further promoted.
Furthermore, continuation of exercise increases the expression
of Sirt 3 in the human body, and Sirt 3 increases
intramuscularly [43,44]. Thus, carbohydrate restriction plus
exercise leads humans to the health and longevity path.
We have discussed concerning LCD and hyperketonemia.
Regarding the future directions and recommendations for
clinical research and treatment, we can speculate as follows
[15,39-41,45]: 1) There are too many patients with diabetes
worldwide associated with diabetic macrovascular and
microvascular complications, 2) Rapid normalization of profile
of blood glucose would be necessary in order to prevent
arteriosclerotic influence with diabetes, 3) For their nutritional
therapy, LCD than CR would be rather recommended for its
beneficial efficacy, 4) It has two benefits, which are rapid
lowering effects of blood glucose and persisting elevated
ketone bodies, 5) hyperketonemia would reduce the risk of
metabolic / cardiovascular / renal / neural systems, anti-
arteriosclerotic effect, anti-cancer action, and so on.
Consequently, obtained data in this study would be a useful
reference for further development of clinical research and
treatment.
Conclusion
Current study revealed that the case treated with super LCD
containing 12% carbohydrate showed detail carbohydrate
intake records for years, remarkable decrease of HbA1c value,
significant correlation between carbohydrate intake and serum
ketone bodies. In elevated ketone bodies, the ratio of AcAc
and 3-OHBA in total ketone bodies were investigated. These
results would become the fundamental data and suppose
future directions and recommendations for research of ketone
bodies in low carbohydrate diet.
Acknowledgement
The authors would like to thank the patients and staffs for
their cooperation and support. The authors declare that they
have no conflicts of interest.
References
1. Atkins R (1998) Dr. Atkins’ new diet revolution. Avon books, New
York.
2. Bernstein RK (2007) Dr. Bernstein’s Diabetes solution: The
complete guide to achieving normal blood sugars. Little, Brown
US, New York.
3. Shai I, Schwarzfuchs D, Henkin Y (2008) Weight loss with a low-
carbohydrate, Mediterranean, or low-fat diet. N Engl J Med 359:
229-241.
4. Schwarzfuchs D, Golan R, Shai I (2012) Four-year follow-up after
two-year dietary interventions. N Engl J Med 367: 1373-1374.
5. Meng Y, Bai H, Wang S, Li Z, Wang Q (2017) Efficacy of low
carbohydrate diet for type 2 diabetes mellitus management: A
systematic review and meta-analysis of randomized controlled
trials. Diabetes Res Clin Pract 131: 124-131.
6. Namazi N, Larijani B, Azadbakht L (2017) Low-carbohydrate-diet
score and its association with the risk of diabetes: A systematic
review and meta-analysis of cohort studies. Horm Metab Res 49:
565-571.
7. Feinman RD, Pogozelski WK, Astrup A, Bernstein RK, Fine EJ, et
al. (2015) Dietary carbohydrate restriction as the first approach
in diabetes management: Critical review and evidence base.
Nutrition 31: 1-13.
8. Ebe K, Ebe Y, Yokota S (2004) Low Carbohydrate diet (LCD)
treated for three cases as diabetic diet therapy. Kyoto Med
Association J 51: 125-129.
9. Bando H, Nakamura T (2008) Carbo-count therapy and low
carbohydrate diet (LCD). The J Therapy 90: 3105-3111.
10. Bando H, Ebe K, Muneta T, Bando M, Yonei Y (2017) Clinical
effect of low carbohydrate diet (LCD): Case report. Diabetes
Case Rep 2: 124.
11. Ebe K, Bando H, Yamamoto K, Bando M, Yonei Y (2018) Daily
carbohydrate intake correlates with HbA1c in low carbohydrate
diet (LCD). J Diabetol 1: 4-9.
12. Muneta T, Kawaguchi E, Nagai Y, Matsumoto M, Ebe K (2016)
Ketone body elevation in placenta, umbilical cord, newborn and
mother in normal delivery. Glycative Stress Research 3: 133-140.
13. Ebe K, Bando H, Muneta T, Bando M, Yonei Y (2017) Effect of low
carbohydrate diet (LCD) for diabetic patients with
hypertriglycemia. Endocrinol Metab 1: 104.
14. Cahill GF (1970) Starvation in man. N Engl J Med 282: 668-75.
15. Watanabe S (2016) Wellness fasting and hyperketosis. Diabetes
Res Open J 2: e10-e13.
16. Laffel L (1999) Ketone bodies: A review of physiology,
pathophysiology and application of monitoring to diabetes.
Diabetes Metab Res Rev 15: 412-426.
17. Cahill GF (2006) Fuel metabolism in starvation. Annu Rev Nutr
26: 1-22.
18. Paoli A (2014) Ketogenic diet for obesity: Friend or foe? Int J
Environ Res Public Health 11: 2092-2107.
19. Freeman JM, Kossoff EH, Hartman AL (2007) The ketogenic diet:
One decade later. Pediatrics 119: 535-543.
20. Yanai H (2015) Four step excel statistics (4th edn.). Seiun-sha
Publishing Co.Ltd, Tokyo.
21. Japan Diabetes Association (2013) Diabetes clinical practice
guidelines based on scientific evidence.
22. The Ministry of Health and Welfare, Japan (2015) National
Health Nutrition Survey Result.
23. American Diabetes Association (2013) Nutrition
recommendations and interventions for diabetes. Diabetes Care
36: S12-32.
Endocrinology and Metabolism: Open Access
Vol.2 No.1:109
2018
© Copyright iMedPub 5
24. International Diabetes Federation (2015) Standards of medical
care in diabetes-2015. Diabetes Care 38: S1-S94.
25. Saslow LR, Kim S, Daubenmier JJ, Moskowitz JT, Phinney SD, et
al. (2014) A randomized pilot trial of a moderate carbohydrate
diet compared to a very low carbohydrate diet in overweight or
obese individuals with type 2 diabetes mellitus or prediabetes.
PLoS ONE 9: e91027.
26. Hussain TA, Mathew TC, Dashti AA, Asfar S, Al-Zaid N (2012)
Effect of low-calorie versus low-carbohydrate ketogenic diet in
type 2 diabetes. Nutrition 28: 1016-1021.
27. Watanabe S, Hirakawa A, Utada I, Aoe S, Moriyama S, et al.
(2017) Ketone body production and excretion during wellness
fasting. Diabetes Res Open J 3: 1-8.
28. Snorgaard O, Poulsen GM, Andersen HK, Astrup A (2017)
Systematic review and meta-analysis of dietary carbohydrate
restriction in patients with type 2 diabetes. BMJ Open Diabetes
Res Care 5: e000354.
29. Bando H, Ebe K, Muneta T, Bando M, Yonei Y (2017) Effect of low
carbohydrate diet on type 2 diabetic patients and usefulness of
M-value. Diabetes Res Open J 3: 9-16.
30. Nilsson LH, Furst P, Hultman E (1973) Carbohydrate metabolism
of the liver in normal man under varying dietary conditions.
Scand J Clin Lab Invest 32: 331-337.
31. Phinney SD, Bistrian BR, Evans WJ, Gervino E, Blackburn GL
(1983) The human metabolic response to chronic ketosis
without caloric restriction: Preservation of submaximal exercise
capability with reduced carbohydrate oxidation. Metabolism 32:
769-776.
32. Zajac A, Poprzecki S, Maszczyk A, Czuba M, Michalczyk M, et al.
(2014) The effects of a ketogenic diet on exercise metabolism
and physical performance in off-road cyclists. Nutrients 6:
2493-2508.
33. Rhyu HS, Cho SY (2014) The effect of weight loss by ketogenic
diet on the body composition, performance-related physical
fitness factors and cytokines of taekwondo athletes. J Exerc
Rehabil 10: 326–331.
34. Volek JS, Freidenreich DJ, Saenz C, Kunces LJ, Creighton BC, et al.
(2016) Metabolic characteristics of keto-adapted ultraendurance
runners. Metabolism 65: 100-110.
35. Ramos-Jimenez A, Hernandez-Torres RP, Torres-Duran PV,
Romero-Gonzalez J, Mascher D, et al. (2008) The respiratory
exchange ratio is associated with fitness indicators both in
trained and untrained men: A possible application for people
with reduced exercise tolerance. Clin Med Circ Respirat Pulm
Med 2: 1-9.
36. Paoli A, Rubini A, Volek JS, Grimaldi KA (2013) Beyond weight
loss: a review of the therapeutic uses of very-low-carbohydrate
(ketogenic) diets. Eur J Clin Nutr 67: 789-796.
37. Matsumoto H (1992) Pathophysiological studies on 59 patients
with diabetic ketoacidosis and immunohistological examination
on pancreatic islets. J Tokyo Wom Med Univ 62: 1598-1607.
38. Krebs HA (1966) The regulation of the release of ketone bodies
by the liver. Adv Enzyme Regul 4: 339-354.
39. Veech RL (2004) The therapeutic implications of ketone bodies:
the effects of ketone bodies in pathological conditions: Ketosis,
ketogenic diet, redox states, insulin resistance, and
mitochondrial metabolism. Prostaglandins Leukot Essent Fatty
Acids 70: 309-319.
40. Kossoff EH, Zupec-Kanici BA, Amask PE (2009) Optimal clinical
management of children receiving the ketogenic diet:
Recommendations of the International Ketogenic Diet Study
Group. Epilepsia 50: 304-317.
41. Shimazu T, Hirschey MD, Newman J (2013) Suppression of
oxidative stress by β-hydroxybutyrate, an endogenous histone
deacetylase inhibitor. Science 339: 211-214.
42. Youm YH, Nguyen KY, Grant RW, Goldberg EL, Bodogai M, et al.
(2015) Ketone body β-hydroxybutyrate blocks the NLRP3
inflammasome-mediated inflammatory disease. Nat Med 21:
263–269.
43. Newman JC, Verdin E (2014) Ketone bodies as signaling
metabolites. Trends Endocrinol Metab 25: 42–52.
44. Edwards C, Copes N, Bradshaw PC (2015) D-ß-hydroxybutyrate:
an anti-aging ketone body. Oncotarget 6: 3477–3478.
45. Kavalek M, Gannon R, Nelson M (2017) A case for and against
ketogenic diets in athletes. Strength and Conditioning Journal
39: 27–31.
 
Endocrinology and Metabolism: Open Access
Vol.2 No.1:109
2018
6 This article is available from: http://www.imedpub.com/endocrinology-metabolism-open-access/
